NCCS and Illumina collaborate for genomics research on rare cancers

It will focus on the profiling of AYA lymphoma patients.

The National Cancer Centre Singapore (NCCS) has signed a collaboration agreement with Illumina to advance genomics research for rare cancers in the country

Through the partnership, the research is set to focus on the profiling of adolescent and young adult (AYA) lymphoma patients from an Asian multiethnic cohort.

In line with this, it will be conducted through leveraging Illumina’s genome sequencing platforms, such as the NovaSeq™ 6000 systems to study the genetic links between health and the disease for better diagnosis and treatment.

“Lymphoma in adolescents and young adults can be challenging to treat,” Jason Chan, director of the Cancer Discovery Hub at NCCS, said.

“As a medical oncologist, I look forward to finding new ways to more effectively target the disease to offer our young patients in Asia personalised and targeted therapies to improve survival rates and enhance their quality of life,” Chan added.

Meanwhile, the Medical Affairs head at Asia Pacific Illumina, Amol Zimur, emphasised their commitment to this partnership with NCCS.

“We are committed to continuing to support the NCCS to gain important insights to improve patient care and outcomes in these groups, as the classification systems used in non-Hodgkin lymphoma historically have not been studied in Asian populations,” Zimur said.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia